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Genetic  studies  have  indicated  that  immunoglobulin  allotypes  are  inherited  as 
codominant Mendelian alleles and that their synthesis is controlled by genes at three 
unlinked loci (1). However, recent evidence has challenged the notion that immunoglobu- 
lin allotypes are encoded by allelic structural genes, and has led to the suggestion that 
individuals may possess complex groups of structural genes, the expression of which is 
governed by specific regulatory genes  (2-4).  The generality of nonallelic behavior of 
allotypes was initially suggested by the frequent occurrence of low levels of latent group 
a allotypes in rabbit sera (5). 
In our laboratory and elsewhere, immunoglobulin and antibody molecules bearing 
latent group a and group d allotypes have been thoroughly characterized using serologi- 
cal, and in some instances, structural techniques (4-9). 1 Nevertheless, questions have 
been raised concerning the validity of latent allotype observations. For example, it has 
been contended that the heterogeneity, multiplicity, and complexity of the heavy chain 
variable region structures on which the group a  allotypic determinants reside make 
unambiguous identification of latent a allotypes an extremely difficult task (10). Others 
have  suggested that latent components may be the  products of lymphoid cells from 
mother  or  siblings  which  enter the  fetus during pregnancy.  These issues  might be 
resolved if serologically distinct, structurally defined latent markers were expressed in 
rabbits of defined pedigree.  Recent serologic (11) and structural  studies  (12-15)  have 
indicated that the group b  allotypes of rabbit light chains are ideally suited for this 
purpose. 
The present study presents evidence for the occurrence of latent b allotypes in 
sera from pedigreed rabbits. Sera from 37 homozygous b4b  4 rabbits were tested 
by a sensitive radioimmunoassay (RIA),  2 and 5 were found to contain significant 
concentrations of either latent b5 or latent b9 allotypes. Furthermore,  in two 
instances,  the  level  of latent  b9  allotypes  was  sufficiently  high  to  permit 
* Latent  allotypes  are  allotypes  not predicted  by breeding  data  nor detected  by normal 
qualitative typing procedures. The term nominal allotype is used for those determined by usual 
typing procedures consistent with breeding data. 
I M.  Mudgett-Hunter,  M.  L. Yarmush,  B. A. Fraser, and T. J.  Kindt.  1978. Rabbit  latent 
group a allotypes: characterization and relationship to nominal  group a allotypic specificities. 
Manuscript submitted for publication. 
Abbreviations used in this paper: BSA, bovine serum albumin; H, heavy; HAS, N-hydroxy- 
succinimide-activated  Sepharose 4B; L, light; PBS, phosphate-buffered saline; RIA, radioimmu- 
noassay. 
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isolation and detailed serologic characterization of the immunogiobulin popula- 
tion bearing this allotype. 
Materials and Methods 
General.  Techniques for preparation of streptococcal vaccines and immunization of rabbits 
have been previously described (16). Rabbits used in this study (allotypes b4b  4) were selectively 
bred at The Rockefeller University to give high antibody responses of restricted heterogeneity 
after streptococcal immunization. Anti-allotype sera were prepared according to the principles of 
Oudin (17) with previously described modifications (1). The presence of anti-allotype antibodies 
was determined by capillary precipitin test,  and the specificity of the antisera was checked by 
RIA (18). Pools of nonimmune IgG from rabbits homozygous for a and b allotypes were purified by 
DEAE-cellulose chromatography using 0.02 M potassium phosphate buffer as eluant (pH 7.0) for 
b4 IgG, 0.03 M phosphate buffer for b5 and b6 IgG, and 0.04 M phosphate buffer for b9 IgG. IgG 
from at least three rabbits was included in each pool. Each pool was checked for the presence of 
latent allotype, and only those pools that tested negative by RIA were used.  IgG concentrations in 
rabbit sera were determined by radial immunodiffusion using goat anti-rabbit Fc-T sera in 1% 
agarose, 0.05 M phosphate-buffered saline (PBS),  pH 7.0  (19). The extent of radial diffusion of 
each sample was measured  al~r 36  h,  and concentrations were assigned by reference to IgG 
standards. The isolation of an homogeneous anti-streptococcal antibody of allotype a3/b9 from the 
transfusion plasma of rabbit 4153 has been previously described (20). 
Immunoadsorbent  Columns.  Columns used for removal of cross-reactive anti-allotype anti- 
bodies were prepared by coupling 50 mg of IgG of known allotype to 25 ml of Sepharose 4B by the 
cyanogen bromide method of Cuatrecasas  (21), and then mixing equal quantities of three IgG 
immunoadsorbents containing the group b allotypes that were expected to be nonreactive with 
the anti-allotype serum under investigation. All immunoadserbent columns used in this study 
were washed with 3 M NI~SCN in PBS, pH 7.0, before use. 
Radioiodination.  In most instances, purified antibody and IgG preparations were radiolabeled 
using iodine monochloride  (22). Occasionally samples  were radioiodinated using  immobilized 
lactoperoxidase (23). 
RIA.  Inselubilized antisera  were prepared by coupling the  sera to N-hydroxysuccinimide- 
activated Sepharose (HAS), as described by Gottlieb et al. (18). All antisera were heat-activated, 
filtered, and passed through the appropriate adsorption column before immobilization. Nominal 
allotypes were determined by RIA as previously described (18). Binding curves were constructed 
using 0.25/~g of radiolabeled antigen and several dilutions of HAS-anti-allotype in a total volume 
of 200/~1. Inhibition analyses were performed using concentrations of antisera that bound 50% of 
the  radiolabeled  antigen.  Latent  b  allotypes were  quantitated  as  described  for the  latent  a 
allotypes (5) with some modification. Inhibitor (100 ~1) and 0.25 p~g of radiolabeled IgG antigen 
(50/~l) were added to Beckman microfuge tubes (Beckman Instruments, Inc., Fullerton, Calif.). 
Antigen was diluted in PBS containing 0.04 M dithiothreitoi and carrier protein. Carrier proteins 
included 1% bovine serum albumin (BSA) and 10% nonimmune rabbit serum which contained a 
50- to 100-fold excess of all group a and b allotypes except the one under investigation. The con- 
tents were mixed thoroughly and allowed to stand at room temperature for 30 rain. Insolubilized 
anti-allotype serum (50 ~1), at a dilution which bound 50% of the radiolabeled antigen, was then 
added and the contents were again thoroughly mixed. The tubes were agitated for 2 h at room 
temperature,  centrifuged,  and  100  pl  of supernatant  fluid was  transferred  to  a  second  tube. 
Supernate and precipitate fractions were counted to determine the percentage of label bound to 
the HAS. Percent binding was calculated as follows: 
P-S 
%  binding  -  p + S -  2B' 
where P is cpm of the precipitate, S is cpm of the supernatant fluid, and B is background cpm, 
Percent inhibition was calculated as described by Kindt et al. (24). Inhibition values <10% were 
considered negative. All inhibitor test sera were heat-inactivated and filtered before assay. 
Heavy (H) and Light (L) Chain Separation.  IgG was separated into H and L chains by mild 
reduction  and  alkylation  followed  by  chromatography  on  $ephadex  G-75 in  10%  acetic acid, 524  LATENT  GROUP b  ALLOTYP{¢S 
according to the principles of Fleischman et al.  (25).  H  chains were stored in distilled water; L 
chains were stored in PBS, pH 7.0. 
Isolation of Anti-Allotype Antibodies.  Anti-b9 antibodies were isolated by applying anti-b9 
sera to an immunoadsorbent column containing 50 mg of a3/b9 IgG covalently attached to 25 ml of 
Sepharose  4B.  After extensive washing  with  PBS,  the  bound  fraction  was  eluted  with  3  M 
NH4SCN, dialyzed against  PBS,  and then passed through  an adsorption column containing all 
allotypic specificities except b9. A total of 18 mg of anti-b9 antibody was isolated from 120 ml of 
anti-b9 serum. 
Isolation of Latent b9 Molecules.  A specific anti-b9 allotype immunoadsorbent was prepared 
by coupling 18 mg of purified anti-b9 antibody to 10 ml of Sepharose 4B. The coupled antibody was 
divided into four acid-washed,  siliconised columns, and each column was conditioned with 10% 
normal rabbit serum containing all allotypic specificities except bg. In a typical experiment, IgG 
from a serum containing latent b9 was radiolabeled and passed through an anti-b9 column. The 
column was washed extensively with PBS and the bound fraction was eluted with 3 M NH4SCN in 
PBS, pH 7.0.  BSA was added to the eluate to a  concentration of 1%, and the resulting mixture 
was dialyzed against PBS. Each sample of isolated, latent b9 antibodies was then passed through 
a fresh column containing 2 ml of Sepharose 4B to which 5 mg of anti-b4 IgG was coupled. The 
effluent was concentrated and tested for binding to various anti-allotype sera. The purpose of the 
second column was to remove rheumatoid factors, denatured protein, and residual b4 antibodies 
which may have nonspecifically bound to the first immunoadserbent column. 
Results 
Listed in Table I are the genotypes of the rabbits in which anti-allotype sera 
were  prepared,  the  immunogens  used,  and  the  antigens  employed  in  the 
inhibition of binding assays. Each anti-allotype serum was prepared in a rabbit 
heterozygous at the b locus and passed through the appropriate  preadsorption 
column before use.  Antisera  were immobilized  on HAS and  tested  for cross- 
reactions with the other three b allotypes. Each anti-allotype serum bound only 
the radiolabeled antigen to which it was directed and showed no binding to the 
three  other  b  allotypes.  Standard  inhibition  curves  for  each  allotype  were 
generated  by  using  increasing  concentrations  of the  appropriate  unlabeled 
allotype pools as inhibitors.  Only homologous pools inhibited the binding of the 
radiolabeled pools to their respective HAS-antiallotype sera,  whereas none of 
the  heterologous  pools gave  significant  inhibition  values  in  the  homologous 
systems.  Illustrated  in  Fig.  1  are  standard  inhibition  curves  for  b5  and  b9 
allotypic reactions. 
Screening for Latent AUotypes.  A search for latent b allotypes was initiated 
using the specific anti-allotype sera described above. Nonimmune sera from 37 
pedigreed homozygous b4b  4 rabbits were tested (Fig. 2). The presence of latent 
allotypes was determined by the  ability of test sera to inhibit  the binding  of 
radiolabeled IgG of known allotype to its anti-allotype serum. Reported in Table 
II are inhibition values obtained using undiluted sera as inhibitor.  Significant 
levels of latent b allotypes were detected in 5 of the 37 sera tested; rabbits 2896 
and 2710  contained  latent  b9, rabbits 3007  and  2667 contained  latent  b5, and 
rabbit 2363 contained beth latent b5 and latent b9. Latent b6 was not detected 
in any of the sera tested. Approximate concentrations of latent allotypes listed 
in Table II were assigned from standard inhibition curves (Fig. 1). 
IgG was isolated from the sera of rabbits 2896,  2710,  and 2363,  concentrated 
threefold,  and  used  as  inhibitor  in  b9  binding  reactions.  Concentrated  IgG 
preparations  from 2896 and 2710 inhibited  >90% of the binding,  whereas only 
60% inhibition was achieved with 2363 IgG (Table HI). MARTIN  L.  YARMUSH AND  THOMAS J.  KINDT  525 
TABLZ  I 
Reagents  Used in This Study 
Specificity  Rabbit*  Genotype  Allotypo of  im- 
munogen 
Allotype of  ra- 
diolabeled  IgG 
antigens 
Anti-b4  4766 
Anti-b5  4285 
Anti-b6  4023 
Anti-b9  4133 
a2aa/bSb  9  3,4  3,4 
a2a~/b~b  9  3,5  3,5 
ala3/blb  ~  1,3,6  3,6 
a~a3/b4b  ~  3,9  3,9 
* Used to  prepare antigen. 






















FIG.  1.  Inhibition of binding of 12sI-IgG pools to HAS anti-allotype sera by various IgG 
pools. (A), inhibition  of binding  of HAS anti-b5 to ~2SI-a3/b5  IgG by a3/b5 IgG (O), by a3/b4 
IgG (a), by a3/b6 IgG (O), and by a3/b9 IgG ([]). (B), inhibition  of binding of HAS anti-b9 
to ~25I-a3b9  IgG by a3/b9 IgG (O), by a3fo4 IgG (A), by a3/b6 IgG (O), and by a3/b5 IgG (O). 
When  homogeneous antibody 4153  was used as radiolabeled  antigen,  how- 
ever, the concentrated  IgG preparation  from 2363 gave nearly 90%  inhibition 
(Table  III).  The  b9  allotypic  determinants  on  L  chains  of  4153  Ab  were 
previously shown to be serologically deficient with respect to the determinants 
of b9 pools and two other homogeneous antibodies (6, 26). This result indicates 
that the latent b9 molecules present in the sera of 2363 also lack one or more of 
the determinants present in normal b9 pools. 
H  and L  chains were separated from IgG of rabbits 3007  and 2710,  and the 
isolated chains were tested for inhibition in the b5 and b9 assays, respectively. 
In both cases, a 360-fold molar excess of L chains gave >85% inhibition, whereas 526  LATENT  GROUP  b  ALLOTYPES 
Fro.  2.  Pedigree of rabbits bred for homozygosity at b locus. All rabbits were typed b4b4 
by RIA (17). Illustrated  are rabbits  typed positive for latent markers  (numbers shown), 
rabbits typed negative (black figures), and untested rabbits (shaded figures). The presence 
of latent allotype was determined by the ability of test sera to inhibit the binding of the 
appropriate radiolabeled IgG pool to its respective HAS anti-allotype serum. Values <10% 
were considered negative. 
TABLE II 




Concentration of latent  Inhibition*  allotype$ 
b5  b9  b5  b9 
%  ~g/ml 
2896  ala3/b4b4  82  27.0 
2710  ala3/b4b4  74  16.0 
2363  ala3/b4b4  19  54  1.5  4.5 
3007  ala3/b4b4  50  4.5 
2667  a2a3/b4b4  39  3.0 
* The  values listed  represent percent inhibition  of binding of the appropriate 
radiolabeled  IgG  pool  to  its  respective  anti-allotype  serum. 
These values were assigned using  standard  inhibition  curves illustrated  in Fig.  1. 
IgG  concentrations  in  test  sera  ranged  from  3.3  to  6.8  mg/ml as  measured by  radial 
immunodiffusion (19). 
an identical molar amount of H  chains did not inhibit to a  significant degree. 
The  lower  inhibition  values  obtained  with  isolated  L  chains  versus  those 
obtained  with  intact  molecules  are  predictably  caused  by  the  suboptimal 
conformation of allotypic determinants on isolated L chains,  and by denatura- 
tion induced during chain separation. 
Immune bleedings from the latent positive rabbits were also examined for the 
presence of latent b  markers.  Sequential observations over a  period of several 
weeks revealed  marked  fluctuations of latent  allotype concentrations.  Repre- 
sentative examples are shown in Fig. 3. MARTIN  L. YARMUSH  AND  THOMAS  J. KINDT 
TABLE  III 
Latent Allotype  Activity  in Concentrated IgG Preparations as 
Measured by RIA 
Maximum  inhibi- 
Rabbit  Radiolabeled antigen  tion 
% 
2896  b9 IgG  96 
2710  b9 IgG  93 
2363  b9 IgG  60 
2896  4153Ab  96 
2710  4153Ab  95 
2363  4153Ab  89 
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FIG. 3.  Latent b5 (dark bars)  and b9 (white bars)  in anti-streptococcal  sera from rabbits 
2710(A) and 2363(B). Latent allotype activity  is represented as the percent inhibition  of 
binding of  the appropriate radiolabeled  IgG pool  to  its  respective  HAS anti-allotype  serum. 
Isolation of Latent b9 Molecules.  To better characterize the latent compo- 
nents in the test sera, molecules bearing the b9 determinants were specifically 
isolated from the sera of rabbits 2896 and 2710. Individual IgG preparations 
were isolated and radiolabeled, and latent b9 antibodies were isolated on anti- 
b9 immunoadsorbents. As seen in Table IV, in both cases, HAS anti-b9 bound 
>75% of the purified preparations, whereas the other immobilized anti-allotype 
~era reacted with <20%  of the molecules. Low binding values obtained with 
anti-b5 and anti-b6 probably represent slight denaturation caused by the elution 
procedure,  whereas binding  values  obtained with  HAS  anti-b4  more likely 
reflect a  slight  contamination of b4  determinants in  the  isolated  latent  b9 
preparations. Binding of the purified preparations to several immobilized IgG 
pools  (b4, b5,  b6,  and b9)  was also below 10%, indicating that anti-allotype 
antibodies were not present in the preparations. In addition, binding of radio- 
labeled latent b9 molecules to anti-b9 could be inhibited only by b9  IgG;  no 
inhibition was observed with b4, b5, or b6 IgG preparations. 528  LATENT  GROUP  b  ALLOTYPES 
TABLe.  IV 
Serologic Characterization of the Isolated Latent b9 Molecules 
Amount  Rabbit  Anti-b4  Anti-b5 
eluted* 
Binding 
Anti-b6  Anti-b9 
p~g  % 
2896  44  17  4  5  80 
2710  31  19  8  5  76 
* 10 mg of radiolabeled IgG was applied to the columns. 
TABLE  V 
Reciprocal Binding of  Latent b9 Molecules from Rabbit 2896 
First  adsorption  Second adsorption 
with:*  Binding  with:  Bindings 
%  % 
Anti-b4  17  Anti-b9  76 
Anti-b9  80  Anti-b4  16 
* 1 ~g of  radiolabeled isolated  material was adsorbed twice with either 
anti-b4 or anti-b9.  The supernatant fractions  were then tested  for 
binding by the  reciprocal  addition  of  the  second antiserum. 
$ This value  represents the  percent of  material bound by  the  addition  of 
the second antiserum multiplied by the percent of  unbound material 
from the first  incubations. 
To ascertain  whether the b4 and b9 determinants  reside  on separate  mole- 
cules,  sequential  binding  experiments  were  conducted  with  the  isolated  ma- 
terial from 2896. The isolated preparation (1 ~g) was adsorbed twice with either 
HAS anti-b4 or HAS anti-bg, and the supernate from the second adsorption was 
tested for binding with the other immobilized antiserum. As shown in Table V, 
when the isolated preparation was incubated twice with HAS anti-b4, a total of 
17% of the molecules was bound. Of the remaining material  (83%),  91.5%  was 
bound by HAS anti-b9.  Thus,  a  minimum of 76% of the material reacted only 
with anti-b9 and not with anti-b4. When adsorptions were carried out in the re- 
verse order,  it was found that  16% of the molecules reacted only with anti-b4 
and not with  anti-bg.  These  observations  indicate  that  a  minimum of 92% of 
the purified preparation consists of allotypically monoreactive molecules. 
The effects of b9 immunoadsorption on the b4 activity in the starting material 
were  also examined.  Unlabeled  IgG from rabbit  2710 was passed through an 
anti-b9 column, and the effluent was tested for its ability to inhibit the b4 and 
b9  allotype  binding  reactions.  Adsorption  removed  >80%  of  the  latent  b9 
activity.  However, this treatment had no effect on the capacity of the sample to 
inhibit the binding of a radiolabeled b4 pool to HAS anti-b4. 
Discussion 
This report documents  the occurrence of latent b aUotypes in sera from 
pedigreed  rabbits. Serologic analysis of sera from  an extended  family  of 
homozygous b4 rabbits  revealed the presence of  latent  b allotypes  in 5 of  the 37 MARTIN  L.  YARMUSH  AND  THOMAS  J.  KINDT  529 
sera tested. Latent b5 and b9 markers were identified; none of the sera tested 
contained latent b6.  N.  Francis and W.  J.  Mandy (personal communication) 
have also recently found unexpected L chain markers (b4, b5, and b6, but not 
b9) in preimmune and immune bleedings from rabbits hyperimmunized with 
ovalbumin. 
Since the initial observation of latent allotype expression, efforts have been 
directed toward proving that these components are identical to those normally 
expressed, thus eliminating explanations for latent allotype activity based on 
serologic artifacts. The b4 and b9 allotypes are especially well-suited for this 
type of study because the polymorphic forms are readily discernible by serologic 
tests (11). Furthermore, amino acid sequence studies of the b4 and b9 allelic 
forms have revealed an unusual degree of structural diversity; their respective 
constant regions differ at ----33% of their positions (13). 
However, because cross-reactions among rabbit group b  allotypes, notably 
between b4, b5, and b6, have been reported (10, 27, 28), care must be taken in 
their determination. One obvious precaution involves the uses of appropriate 
heterozygotes  for serum preparation (11). In order to insure that b locus antisera 
used in this study were monospecific, antisera were raised in rabbits heterozy- 
gous  at  the  b  locus,  and  were  then  passed  through  adsorption  columns 
containing an IgG pool with all the group a and b specificities except the one 
against which the antiserum was directed. All antisera prepared in this fashion 
were free of cross-reactivity by the criteria of binding and inhibition of binding 
analyses with  allotypically homozygous IgG  pools.  In  addition,  rabbit  sera 
containing all  the  allotypes except the  one  in  question were  added to  the 
inhibition assays. Using such measures, it has already been shown that latent 
group a activity measured by our radioimmunoassay reflects neither nonspecif- 
icity nor anti-globulin activity.1 The results presented here also eliminate these 
interpretations as explanations for latent b  activity. Latent b  allotypes were 
detected in IgG preparations and on isolated light chains, and latent molecules 
isolated on anti-allotype columns showed little or no binding to normal IgG. 
Finally,  the  identification of latent markers in  rabbits  of defined pedigree 
precludes  the  possibility  that  latent  allotypes  are  derived  as  a  result  of 
permanent chimerism arising from transplacental passage of lymphoid cells 
during pregnancy. 
The values listed in column four of Table II deserved extended comment. In 
general, inhibition values and not absolute concentrations have been reported 
in this paper.  By comparison of these values with inhibition values obtained 
using known amounts of homologous inhibitor, concentration values may be 
obtained as they were for the purposes of this table. It must be emphasized that 
the  extrapolated concentrations are only a  convenient way to  report latent 
allotype  activity  and  would  have  physical  significance  only  if  the  latent 
allotypes could be  shown  by  alternative  means to  be  identical  to  nominal 
allotypes. Because rabbit group a  and b  allotypes are each multideterminant 
antigenic  species,  mathematical  analysis  of classical  binding  or  inhibition 
curves can yield only average apparent association constants. Quantitation by 
comparison to standard inhibition curves is possible only if each molecule bears 
all  of the  determinants recognized by the  appropriate  anti-allotype serum. 530  LATENT  GROUP  b  ALLOTYPES 
However, this is not the case. Subspecificities of group a allotypes are common 
and well-characterized (24, 29-31), and subspecificities of group b  allotypes, 
although less common, have been reported (6, 26). In this situation, inhibition 
values  will  be  dependent on  the  subspecificity distributions  in  the  labeled 
antigen, the homologous inhibitor, and the experimental inhibitor, and on the 
spectrum of subspecificity recognition by the anti-allotype serum. Thus, until 
independent, complementary, structurally-based quantitation of the molecules 
bearing the latent allotype is obtained, concentration values for latent allotypes 
will remain tentative. 
It was of particular interest to ascertain whether molecules expressing latent 
b allotypes comprise a subset of molecules with dual allotypic reactivity. Recent 
studies have suggested that  individual IgG molecules from members of the 
Sylvilagus and  Lepus genera,  may possess  determinants belonging to  more 
than one group b allotype (32-35). For example, in one study (34), five different 
b  allotype phenogroups were identified among eight cottontails tested: b(4)', 
b(6)',  b(4,6)',  b(4,5,6)',  and  b(4,6,9)'.  All  cottontail IgG preparations bound 
group b anti-allotype sera prepared in domestic rabbits, but these IgG prepara- 
tions were found to be poor or ineffective inhibitors of binding of domestic rabbit 
IgG to anti-allotype sera. In studies on rabbit a-locus markers (36), van der Loo 
et al. have reported that most domestic rabbits of allotype al produce a popula- 
tion of molecules which can be detected with a3  anti-a2 sera.  Because these 
molecules were found in significant concentrations in sera of normal hares, the 
authors suggested that the hare-like molecules expressed in domestic rabbits 
may  be  encoded  by  phylogenetically ancient  genes  which  have  remained 
structural components of the oryctolagus genome. 
The data reported here, however, indicate that latent b  allotype molecules 
are allotypically monoreactive and serologically identical to nominal allotypes. 
It is,  therefore, unlikely that the latent group b allotypes described here and 
the latent H chain allotypes described previously are products of unidentified 
ancient genes or phenogroups. Although the behavior of latent allotypes in 
serologic analysis parallels that of their nominal counterparts, final confirma- 
tion of identity between latent and nominal forms awaits complete structural 
analysis. 
It is obvious that genetic models formulated to account for antibody diversity 
must be expanded to accommodate these and other similar data. The presence 
of unexpected immunoglobulin gene  products  argues  that  structural  genes 
encoding these  molecules  must  be  present  in  the  individual.  It  has  been 
suggested  that  the  genetic  information  for  every  allotype  exists  on  each 
chromosome as linked genes, and that the allelic behavior of antibody expres- 
sion is conferred by regulator genes (2). A  possible  alternative involves the 
existence of two (or more) closely linked allelic genes for each allotype locus on 
each chromosome: one of which is activated, encoding nominal allotypes, and 
the other(s); silent, encoding latent allotypes. Thus, for example, if only two b- 
locus genes were present on each chromosome, a homozygous individual could 
express one or two but never three latent allotypes.  Studies on the effect of 
genetic background on  latent  allotype expression are  in  progress  and  may 
provide some insight into the genetic mechanisms governing allotype expres- 
sion. MARTIN  L.  YARMUSH  AND  THOMAS  J.  KINDT  531 
Summary 
Latent group b markers were detected in sera, in IgG preparations,  and on 
isolated L chains from rabbits bred for homozygosity at the b locus. Serologic 
analysis of sera from an extended family of homozygous b4 rabbits revealed the 
presence of latent b allotypes in 5 of 37 sera tested. Latent b5 and b9 markers 
were identified; none of the sera tested contained latent b6. In two instances, 
the level of latent b9 allotypes  was sufficiently high to permit isolation and 
detailed  serologic characterization  of the immunoglobulin  population bearing 
this allotype. The fact  that latent allotypes were detected in pedigreed homozy- 
gous rabbits minimizes the possibility that lymphoid cell  chimerism is involved 
in latent  allotype  expression.  Furthermore,  characterization  of the b9 IgG 
population indicates that the latent allotypic determinants  do not reside on a 
subset of  molecules with dual allotypic reactivity. 
Received for publication 24 April 1978. 
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